{"id":"https://openalex.org/W2947921300","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.e18184","title":"Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors.","display_name":"Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947921300","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.e18184","mag":"2947921300"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.e18184","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.e18184","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.e18184","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062592912","display_name":"Lorenzo Gervaso","orcid":"https://orcid.org/0000-0003-3313-8527","observed_orcids":["https://orcid.org/0000-0003-3313-8527"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lorenzo Gervaso","raw_affiliation_strings":["Cleveland Clinic - Taussig Cancer Institute, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic - Taussig Cancer Institute, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024618610","display_name":"Alberto J. Montero","orcid":"https://orcid.org/0000-0002-8221-8120","observed_orcids":["https://orcid.org/0000-0002-8221-8120"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alberto J. Montero","raw_affiliation_strings":["NSABP Foundation, Cleveland Clinic, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NSABP Foundation, Cleveland Clinic, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101184210","display_name":"Xuefei Jia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xuefei Jia","raw_affiliation_strings":["Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039576853","display_name":"Alok A. Khorana","orcid":"https://orcid.org/0000-0002-9509-0998","observed_orcids":["https://orcid.org/0000-0002-9509-0998"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alok A. Khorana","raw_affiliation_strings":["Cleveland Clinic- Taussig Cancer Institute, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic- Taussig Cancer Institute, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"e18184","last_page":"e18184"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.49729999899864197,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":1.0},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.8920000195503235},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9020000100135803},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.921999990940094},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.996999979019165},{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":1.0},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pulmonary-embolism","display_name":"pulmonary embolism","score":1.0},{"id":"https://openalex.org/keywords/real-world-incidence","display_name":"real-world incidence","score":0.765999972820282},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.765999972820282},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9879999756813049},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.6850000023841858},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9554165005683899},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.7529594898223877},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.68058180809021},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6477116346359253},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6075526475906372},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5141173005104065},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5079835057258606},{"id":"https://openalex.org/C2776265017","wikidata":"https://www.wikidata.org/wiki/Q220570","display_name":"Pulmonary embolism","level":2,"score":0.4929947555065155},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4428063929080963},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.4215267300605774},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3910277783870697},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33998534083366394},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.3349456191062927},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.2985319197177887},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.13759952783584595},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.e18184","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.e18184","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.e18184","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3203106735","https://openalex.org/W3161515104","https://openalex.org/W2769683585","https://openalex.org/W2480965698","https://openalex.org/W4385476556","https://openalex.org/W4200136212","https://openalex.org/W2966855990","https://openalex.org/W2802389486","https://openalex.org/W4210904940","https://openalex.org/W2731600971"],"abstract_inverted_index":{"e18184":[0],"Background:":[1],"Venous":[2],"thromboembolism":[3],"(VTE)":[4],"complicates":[5],"several":[6],"anti-cancer":[7],"regimens":[8],"including":[9,151,245],"chemotherapy":[10],"and":[11,49,70,103,156,174,184,258,275,287,346],"anti-angiogenic":[12],"agents.":[13],"Cyclin-dependent":[14],"kinase":[15],"4/6":[16],"inhibitors":[17],"(CDKIs)":[18],"are":[19,67],"a":[20,115,203],"new":[21],"approach":[22],"for":[23,41,46,51,186],"hormone":[24],"receptor":[25],"positive":[26],"(HR+)":[27],"metastatic":[28],"breast":[29,323],"cancer":[30,324],"(mBC).":[31],"Reported":[32],"VTE":[33,84,99,150,177,189,233,271,280,318],"rates":[34,59,97],"in":[35,63,87,100,107,238,247,253,263,334],"randomized":[36],"trials":[37],"range":[38],"from":[39,146],"0.6%":[40],"ribociclib":[42],"(MONALEESA-2)":[43],"to":[44,61,95,176,270,329,341],"2%":[45],"palbociclib":[47],"(PALOMA-3)":[48],"5%":[50],"abemaciclib":[52],"(MONARCH-3)":[53],"but":[54,289],"these":[55],"may":[56],"underestimate":[57],"actual":[58],"compared":[60],"patients":[62,109,135,226,241,325],"clinical":[64,101],"practice":[65,102],"who":[66,136],"generally":[68],"older":[69],"have":[71],"greater":[72,331],"comorbidities.":[73],"Little":[74],"is":[75,339],"known":[76],"about":[77],"real":[78],"world":[79],"incidence":[80],"or":[81],"prevalence":[82],"of":[83,91,98,139,208,240,322,348],"with":[85,105,188,202,283],"CDKIs":[86,142],"mBC.":[88],"The":[89,196],"aim":[90],"this":[92,290],"study":[93,118,197],"was":[94,215,272,278,281,291],"evaluate":[96],"association":[104,187],"outcomes":[106],"mBC":[108,134],"on":[110],"CDKIs.":[111],"Methods:":[112],"We":[113,131],"conducted":[114],"retrospective":[116],"cohort":[117],"at":[119,206],"Cleveland":[120],"Clinic":[121],"Taussig":[122],"Cancer":[123],"Institute,":[124],"approved":[125],"by":[126,162,180],"the":[127,181,216],"institutional":[128],"review":[129],"board.":[130],"identified":[132,161],"consecutive":[133],"received":[137,228],"any":[138],"three":[140],"FDA-approved":[141],"(palbociclib,":[143],"ribociclib,":[144],"abemaciclib)":[145],"1/2015":[147],"through":[148],"12/2017.":[149],"deep":[152],"venous":[153],"thrombosis":[154,261],"(DVT)":[155],"pulmonary":[157],"embolism":[158],"(PE)":[159],"were":[160,178],"electronic":[163],"medical":[164],"record":[165],"review.":[166],"Overall":[167],"survival":[168,172],"(OS),":[169],"progression":[170],"free":[171],"(PFS)":[173],"time":[175,269],"estimated":[179],"Kaplan-Meier":[182],"method":[183],"evaluated":[185],"using":[190],"Cox":[191],"proportional":[192],"hazard":[193],"regression.":[194],"Results:":[195],"population":[198],"included":[199],"424":[200],"patients,":[201],"median":[204],"age":[205],"diagnosis":[207],"54.76":[209],"yrs,":[210],"(range":[211],"27":[212,225],"-85).":[213],"Palbociclib":[214],"most":[217],"commonly":[218],"used":[219],"CDKI":[220,235],"(n":[221,242,249,255,265],"=":[222,243,250,256,266,304,315],"390,":[223],"91.8%);":[224],"(6.3%)":[227],"more":[229],"than":[230,332],"one":[231],"drug.":[232],"during":[234],"therapy":[236],"occurred":[237],"9%":[239],"38),":[244],"DVT":[246],"52.6%":[248],"20),":[251],"PE":[252],"18.5%":[254],"7)":[257],"visceral":[259],"vein":[260],"(VVT)":[262],"15.8%":[264],"6).":[267],"Median":[268],"314":[273],"days,":[274],"6-months":[276],"rate":[277],"4.1%.":[279],"associated":[282],"numerically":[284],"worse":[285],"PFS":[286],"OS,":[288],"not":[292],"statistically":[293],"significant":[294],"(PFS":[295],"[HR":[296,307],"1.25,":[297],"95%":[298,309],"CI":[299,310],"0.73":[300],"\u2013":[301,312],"2.14,":[302],"p":[303,314],"0.42],":[305],"OS":[306],"1.60,":[308],"0.89":[311],"2.87,":[313],"0.12]).":[316],"Conclusions:":[317],"affected":[319],"nearly":[320],"10%":[321],"receiving":[326],"CDKIs,":[327],"2-":[328],"5-fold":[330],"reported":[333],"registration":[335],"trials.":[336],"Further":[337],"work":[338],"necessary":[340],"identify":[342],"pathophysiology,":[343],"risk":[344],"factors":[345],"benefit":[347],"thromboprophylaxis.":[349]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2025-10-10T00:00:00"}